Successful high-dose intravenous immunoglobulin therapy for a patient with fulminant myocarditis

Heart and Vessels

Volumn 22, Issue 1, 2007, Pages 48-51

  Kato, Shigeru ^a   Morimoto, Shin Ichiro ^a   Hiramitsu, Shinya ^a   Uemura, Akihisa ^a   Ohtsuki, Masatsugu ^a   Kato, Yasuchika ^a   Miyagishima, Kenji ^a   Mori, Nami ^a   Hishida, Hitoshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fulminant myocarditis; Immuno globulin; Percutaneous cardiopulmonary support

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 6; METHYLPREDNISOLONE;

ADD ON THERAPY; ADULT; AORTA BALLOON; ARTICLE; CASE REPORT; CELL INFILTRATION; CYTOLYSIS; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART ASSIST DEVICE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE BIOPSY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ENDOCARDIUM; HEART-ASSIST DEVICES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; SHOCK, CARDIOGENIC; STROKE VOLUME;

EID: 33947589429     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-006-0923-3     Document Type: Article

References (21)

1. D Lewes DJ Rainford WF Lane 1974 Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infection Br Heart J 36 924-932 4425607 1:STN:280:CSqD3srpsVI%3D
2. EB Liebermann GM Hutchins A Herskowitz NR Rose KL Baughman 1991 Clinicopathologic description of myocarditis J Am Coll Cardiol 18 1617-1626
3. S Kato S Morimoto S Hiramitsu A Uemura M Ohtsuki Y Kato K Miyagishima Y Yoshida S Hashimoto H Hishida 2004 Risk factors for developing a fulminant course in patients with acute myocarditis Circ J 68 734-739 15277731 10.1253/circj.68.734
4. S Kato S Morimoto S Hiramitsu M Nomura T Ito H Hishida 1999 Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis Am J Cardiol 83 623-625 10073879 10.1016/S0002-9149(98)00931-X 1:STN:280:DyaK1M7ntFyrtQ%3D%3D
5. K Kawahito S Murata Y Misawa K Fuse K Shimada 1998 Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse Am J Cardiol 82 910-911 9781978 10.1016/S0002-9149(98)00503-7 1:CAS:528:DyaK1cXntFGrtr8%3D
6. K Shioji Y Matsuura T Iwase S Kitaguchi H Nakamura J Yodoi T Hashimoto C Kawai C Kishimoto 2002 Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin (a case report) Circ J 66 977-980 12381097 10.1253/circj.66.977
7. JW Mason JB O'Connell A Herskowitz NR Rose BM McManus ME Billingham TE Moon 1995 A clinical trial of immunosuppressive therapy for myocarditis N Engl J Med 333 269-275 7596370 10.1056/NEJM199508033330501 1:CAS:528:DyaK2MXntlKhtrc%3D
8. JW Newburger M Takahashi AS Beiser JC Burns J Bastian KJ Chung SD Colan CE Duffy DR Fulton MP Glode 1991 A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1633-1639 1709446 1:STN:280:By6B3s3lsFw%3D
9. NA Drucker SD Colan AB Lewis AS Beiser DL Wessel M Takahashi AL Baker AR Perez-Atayde JW Newburger 1994 Gamma-globulin treatment of acute myocarditis in the pediatric population Circulation 89 252-257 8281654 1:STN:280:ByuC3cbgt1Y%3D
10. MC Dalakas I IIIa JM Dambrosia SA Soueidan DP Stein C Otero ST Dinsmore S McCrosky 1993 A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993-2000 8247075 10.1056/NEJM199312303292704 1:STN:280:ByuD28jis1U%3D
11. C Kishimoto N Takamatsu H Kawamata H Shinohara H Ochiai 2000 Immunoglobulin treatment ameliorates murine myocarditis associated with reduction of neurohumoral activity and improvement of extracellular matrix change J Am Coll Cardiol 36 1979-1984 11092674 10.1016/ S0735-1097(00)00978-5 1:CAS:528:DC%2BD3MXhs1Gi
12. C Kishimoto H Takada Y Hiraoka 1995 Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects Circulation 92 1604-1611 7664447
13. HM Wolf MM Eibl 1996 Immunomodulatory effect of immunoglobulins Clin Exp Rheum 14 Suppl 15 17-25
14. FS Rosen 1993 Putative mechanisms of the effect of intravenous α-globulin Clin Immunol Immunopathol 67 S41-S43 8500280 10.1006/ clin.1993.1082 1:CAS:528:DyaK3sXmt1emtr0%3D
15. DM McNamara WD Rosenblum KM Janosko MK Trost FS Villaneuva AJ Demetris 1997 Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy Circulation 95 2476-2478 9184576 1:CAS:528:DyaK2sXjvFyrsLo%3D
16. MC Dalakas 2004 Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2367-2375 15150209 10.1001/jama.291.19.2367 1:CAS:528:DC%2BD2cXkt1Sjsbo%3D
17. K Kawamura Y Kitaura H Morita H Deguchi M Kotaka 1985 Viral and idiopathic myocarditis in Japan: A questionnaire survey Heart Vessels Suppl 1 18-22 3916472 10.1007/BF02072353 1:STN:280:BiiB2sbnsVY%3D
18. K Kitamura Y Mikami 2002 Analysis of the physicochemical and biochemical property of various intravenous immunoglobulin preparations (in Japanese) Biotherapy 16 5 467-476 1:CAS:528:DC%2BD38XotlajsL8%3D
19. K Shioji C Kishimoto S Sasayama 2001 Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis. Concomitant suppression of the expression of dendritic cells Circ Res 89 540-546 11557742 1:CAS:528:DC%2BD3MXntFGhsrc%3D
20. C Kishimoto K Shioji M Kinoshita T Iwase S Tamaki M Fuji A Murashige H Maruhashi S Takeda H Nonogi T Hashimoto 2003 Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress Int J Cardiol 91 173-178 14559127 10.1016/S0167-5273(03)00002-0
21. Z Yuan C Kishimoto H Sano K Shioji Y Xu M Yokode 2003 Immunoglobulin treatment suppresses atherosclerosis in apolipoprotein E-deficient mice via the protein Am J Physiol 285 H899-H906 1:CAS:528:DC%2BD3sXmsVagtrg%3D